X-72579737-T-TACAC

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_002637.4(PHKA1):​c.*1261_*1264dupGTGT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0033 ( 1 hom., 87 hem., cov: 19)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control

Consequence

PHKA1
NM_002637.4 3_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.62

Publications

0 publications found
Variant links:
Genes affected
PHKA1 (HGNC:8925): (phosphorylase kinase regulatory subunit alpha 1) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the skeletal muscle isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9D, also known as X-linked muscle glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. A pseudogene has been found on chromosome 1.[provided by RefSeq, Feb 2010]
PHKA1 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXd
    Inheritance: XL, AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00326 (346/106240) while in subpopulation AFR AF = 0.0109 (318/29085). AF 95% confidence interval is 0.00994. There are 1 homozygotes in GnomAd4. There are 87 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 87 XL,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHKA1NM_002637.4 linkc.*1261_*1264dupGTGT 3_prime_UTR_variant Exon 32 of 32 ENST00000373542.9 NP_002628.2 P46020-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHKA1ENST00000373542.9 linkc.*1261_*1264dupGTGT 3_prime_UTR_variant Exon 32 of 32 1 NM_002637.4 ENSP00000362643.4 P46020-1
PHKA1ENST00000339490.7 linkc.*1261_*1264dupGTGT 3_prime_UTR_variant Exon 31 of 31 1 ENSP00000342469.3 P46020-2
PHKA1ENST00000541944.5 linkc.*1261_*1264dupGTGT 3_prime_UTR_variant Exon 30 of 30 1 ENSP00000441251.1 P46020-3
PHKA1ENST00000373545.7 linkc.*1261_*1264dupGTGT 3_prime_UTR_variant Exon 32 of 32 5 ENSP00000362646.3 A6NIT2

Frequencies

GnomAD3 genomes
AF:
0.00324
AC:
344
AN:
106218
Hom.:
1
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.0109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000288
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00431
Gnomad NFE
AF:
0.0000975
Gnomad OTH
AF:
0.00211
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
36
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
22
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
33
Other (OTH)
AF:
0.00
AC:
0
AN:
3
GnomAD4 genome
AF:
0.00326
AC:
346
AN:
106240
Hom.:
1
Cov.:
19
AF XY:
0.00289
AC XY:
87
AN XY:
30148
show subpopulations
African (AFR)
AF:
0.0109
AC:
318
AN:
29085
American (AMR)
AF:
0.00183
AC:
18
AN:
9850
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2534
East Asian (EAS)
AF:
0.000289
AC:
1
AN:
3463
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2450
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5265
Middle Eastern (MID)
AF:
0.00469
AC:
1
AN:
213
European-Non Finnish (NFE)
AF:
0.0000975
AC:
5
AN:
51272
Other (OTH)
AF:
0.00208
AC:
3
AN:
1441
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Glycogen phosphorylase kinase deficiency Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.6
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111688568; hg19: chrX-71799587; API